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Proteasomal degradationHIV-2 Vpx, a virus-associated accessory protein, is critical for infection of non-dividing myeloid cells. To under-
stand the function of Vpx ubiquitination, interactionwith an E3 ubiquitin ligase complex, and ability to overcome
an inhibition of reverse transcription,we analyzed Vpx lysinemutants for their function and replication capability
in macrophages. BothWt Vpx and Vpx TA (lysine-less Vpx) localized to the cytoplasm and nucleus in HeLa cells.
All HIV-2 Vpx lysine mutants were functional in virion packaging. However, ubiquitination was absent with Vpx
TA and Vpx K84Amutants, indicating a lack of ubiquitin on positions K68 and K77. Mutants Vpx K68A and K77A
were unable to infect macrophages due to impaired reverse transcription from loss of interaction with the
ubiquitin substrate receptor, DCAF1. Even though Vpx K84A lacked ubiquitination, it bound DCAF1, and
infected macrophages comparable to Wt Vpx.
© 2012 Elsevier Inc. All rights reserved.Introduction
HIV infects non-dividing cells such asmacrophages and dendritic cells
(DCs). Once infected, these cells help to propagate and disseminate the
virus throughout the host (Hirsch et al., 1998). The viral life cycle requires
reverse transcription and transportation of the viral genetic material to
the nucleus, as part of the pre-integration complex (PIC). The mechanics
of cyto-nuclear translocation of the PIC have not beendelineated although
several viral proteins have been implicated in this process, including inte-
grase (IN), matrix (MA), viral protein R (Vpr) for HIV-1, and viral protein
X (Vpx) for HIV-2/SIV (Depienne et al., 2000).
All HIV/SIV strains encode for Vpr, but members of HIV-2/SIVSM/
SIVMAC also encode for Vpx, a 12–16 kDa virion-associated accessory
protein that is essential for early viral replication in macrophages
(Guyader et al., 1989; Hirsch et al., 1998; Lu et al., 1993). The se-
quence of Vpx is similar to that of Vpr, and the vpx gene was pro-
posed to have arisen through a gene-duplication event (Tristem et
al., 1990). Nevertheless, the functions of Vpr and Vpx are distinct.
Vpr, but not Vpx, induces cell cycle arrest and apoptosis (Belzile et
al., 2007; Fletcher et al., 1996). Vpx, however, promotes reverse tran-
scription and nuclear import of viral PICs in non-dividing cellsAve., Washington University
314 747 2120.
rights reserved.(Belshan et al., 2006; Fujita et al., 2008; Goujon et al., 2007; Hirsch
et al., 1998). Both, Vpr and Vpx are incorporated into virions in quan-
tities comparable to the viral Gag protein, although one study points
to a smaller ratio of Vpr to Gag in virions (Kewalramani and
Emerman, 1996; Muller et al., 2000).
Viruses modulate cells by hijacking cellular complexes and path-
ways (Fujimuro et al., 2007; Goff, 2007). One of the cellular systems
that is hijacked is the ubiquitin proteasome system (UPS), which is
responsible for ubiquitination and degradation of proteins (Horvath,
2004; Leupin et al., 2005; Margottin et al., 1998; Mehle et al., 2004).
Ubiquitination is a post-translational modiﬁcation of proteins that
not only regulates the steady-state levels of proteins, but also regulates
other functions, including transcription and cyto-nuclear translocation
(Hershko and Ciechanover, 1998). In conjunction with the ubiquitin-
activating E1 and E2 proteins, ubiquitin E3 ligases conjugate ubiquitin
to lysine residues present in substrates. Cullin4A-RING E3 ubiquitin li-
gase complex, composed of the cullin4A (CUL4A) scaffold protein, dam-
aged DNA binding protein 1 (DDB1) adaptor, and DDB1 and
CUL4A-associated factor 1 (DCAF1) substrate receptor is comman-
deered by Vpr to cause G2 arrest (Angers et al., 2006; Belzile et al.,
2010; Belzile et al., 2007; Higa et al., 2006; Le Rouzic et al., 2007; Zhao
et al., 1994). Vpx also interacts with the CUL4A–DDB1–DCAF1 complex,
but instead of causing G2 arrest, Vpx is thought to direct ubiquitination
and degradation of a restriction factor that has recently been identiﬁed
as SAMHD1 (Hrecka et al., 2011; Laquette et al., 2011; Le Rouzic et al.,
2007; Wen et al., 2007). The SAMHD1 mechanism of restriction is
not fully understood as it fails to restrict viral infection in
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expressed in these cells (Hrecka et al., 2011). The siRNA knock down of
DCAF1 inhibits reverse transcription in macrophages, highlighting the
importance of Vpx–DCAF1 interaction in viral replication (Bergamaschi
et al., 2009; Fletcher et al., 1996; Fujita et al., 2008; Goujon et al., 2007;
Srivastava et al., 2008). Mutation of residue Q76 in Vpx, which disrupts
Vpx–DCAF1 interaction, also results in an HIV-2 growth defect inmacro-
phages (Bergamaschi et al., 2009; Le Rouzic et al., 2007).
SIV Vpx was shown to be modiﬁed by ubiquitin and a suggestion
was made that Vpx is ubiquitinated on residues other than lysine
(Sharova et al., 2008). This study suggested that lack of Vpx ubiquiti-
nation led to decreased macrophage infection, and no association
with DDB1. Ubiquitin addition to non-lysine residues is not new but
so far it is found infrequently. Wang and colleagues have shown
that serines and threonines can be modiﬁed with ubiquitin on
MHC-I and Tokarev et al. indicated that Vpu leads to ubiquitination
of serine/threonine on BST-2 to induce its down-regulation
(Tokarev et al., 2011; Wang et al., 2007). The objective of this study
was to analyze the effects of lysine substitutions in HIV-2 Vpx on ubi-
quitination, and function of Vpx lysine mutants in macrophage infec-
tion. We show that mutation of all three lysines or individual lysine
residues in HIV-2 Vpx does not affect Vpx expression or incorporation
into HIV-2 virions. In this study, we show ubiquitination only on K84.
However, K84 ubiquitination is dispensable for DCAF1 interaction and
macrophage infection.
Results
Many vpxmutations have beenmade in order to study Vpx function,
however, few studies examined the importance of Vpx lysine residues,
and only one manuscript reported on ubiquitination of Vpx from SIV
(Sharova et al., 2008). To determine the effect of lysine substitutions
on Vpx function, we engineered lysine-to-alanine substitutions in Vpx
from the HIV-2 GH-1 isolate. Single Vpx substitutions were made at
lysine positions 68, 77, and 84, and a triple substitution, designated TA
(triple alanine), was made in all three lysines (Fig. 1). All Vpx mutants
were fused to a 6xHis tag at the N-terminus. None of the lysine substi-
tutions hindered Vpx expression in 293T cells (Fig. 1).
Localization of Vpx lysine mutants
To determine the cellular localization of Vpx lysine mutants, we
transiently transfected HeLa cells that were seeded on coverslips.
Confocal microscopy revealed that Vpx Wt was localized to both the
cytoplasm and the nucleus in approximately 80% of cells (Fig. 2).VpxWt             6xHis --------- SYTKYRYLCLMQKAVFIHFKRGCTCLGRGHG --------
VpxTA             6xHis --------------- A --------------- A --------- A ------------------------------
VpxK68A        6xHis --------------- A --------------- K --------- K ------------------------------
VpxK77A        6xHis --------------- K --------------- A --------- K ------------------------------
VpxK84A        6xHis --------------- K --------------- K --------- A ------------------------------
65 68 77 84 95
  Mock           Wt           TA         K68A      K77A      K84A   6xHisVpx:
Vpx-
-13
kDa
Fig. 1. Schematic representation of the 6xHis-tagged HIV-2 Vpx constructs and their
expression. Schematic depiction of Vpx lysine residues that were individually substituted
for alanine at positions 68, 77, 84 and in triple combination, TA (triple alanine), in which
case every lysine in Vpx is substituted. All constructs were N-terminally labeled with
6xHis tag. Only partial amino acid sequences are shown for Vpx. Western blot showing
the expression of the 6xHis-tagged Vpx mutants. HEK 293T cells were transfected with
mock, 6xHis-tagged Vpx wild-type (Wt), 6xHis-tagged Vpx triple alanine (TA), 6xHis-
tagged Vpx K68A, 6xHis-tagged Vpx K77A, and 6xHis-tagged Vpx K84A constructs. Forty
eight hours post-transfection, cells were lysed and proteins were resolved by SDS-PAGE.
Blots were analyzed for Vpx expression using an anti-Vpx mAb.Out of a 100 cells expressing Vpx Wt, 81 cells showed Vpx localized
to the cytoplasm and nucleus (0 cells had Vpx in a perinuclear aggre-
gation), and 2 cells had Vpx localized to the cytoplasm, and 17 were
nuclear. Out of 100 cells expressing Vpx TA, 78 cells showed Vpx lo-
calized to the cytoplasm and nucleus (23 cells had perinuclear aggre-
gation), 6 cells had Vpx localized to the cytoplasm, and 16 cells had
Vpx with nuclear localization. There was little difference in the local-
ization pattern between the Vpx mutants with single lysine substitu-
tions (data not shown). Even though the Vpx TA mutant had a similar
pattern of cytoplasmic and nuclear localization compared to Vpx Wt,
23% of those cells had a phenotype in which Vpx TA aggregated
around the nucleus (characteristic aggregate photo of Vpx TA is
shown in Fig. 2).
Packaging of Vpx lysine mutants into virus particles
Vpx incorporation has been delineated to the interaction between
p6 of Gag and Vpx residues Leu74 and Ile75, although some muta-
tions, substitution of other residues at positions 73–89 to alanines,
decrease incorporation of Vpx into virions (Jin et al., 2001; Rajendra
Kumar et al., 2005). To determine if the Vpx lysine substitutions affect
incorporation of Vpx into HIV-2 virions, we trans complemented the
HIV-2 proviral clone (pESdelX) that has an impaired vpx coding region
with plasmids encoding the Vpx lysine mutants. For this purpose, tran-
sient co-transfection of 293T cells with pESdelX and 6xHis-tagged Vpx
lysine mutants was carried out. All of the Vpx lysine mutants were in-
corporated into HIV-2 virions, and none of the Vpx lysine substitutions,
individually or in the triple combination, had a signiﬁcant effect on the
efﬁciency of Vpx packaging into virus particles (Fig. 3). Absence of a Vpx
band in pESdelX lane is due tomutations in vpx at the initiating and ﬁrst
internal methionine, plus a frameshift that introduces a termination
codon at position 70 (Hu et al., 1989).
Ubiquitination of HIV-2 Vpx using K48R ubiquitin mutant
Several studies demonstrated that Vpr and Vpx take advantage of
the cellular ubiquitin machinery by hijacking the CUL4A–DDB1–
DCAF1 E3 ubiquitin ligase complex to degrade a viral restriction factor
(Bergamaschi et al., 2009; Le Rouzic et al., 2007; Sharova et al., 2008).
Since Vpx plays a role in commandeering the cellular ubiquitin sys-
tem, we wanted to determine the ubiquitination status of HIV-2
Vpx mutants.
In our study, we show that Vpx is post-translationally modiﬁed, as
seen by the presence of higher molecular bands detected with an
anti-Vpx mAb in lysates of cells transfected with 6xHis-tagged Vpx
Wt (Fig. 4A). To determine the ubiquitination status of HIV-2 Vpx,
and to examine the importance of ubiquitinated Vpx, the 6xHis-
tagged Vpx lysine mutants were transfected into 293T cells in con-
junction with a plasmid that encodes a Flag-tagged ubiquitin K48R
mutant (Ward et al., 1995). The ubiquitin K48R, which is deﬁcient
in the formation of polyubiquitin chains at position K48, and thus
lacks the ability to tag substrates for proteasomal degradation, was
used to enrich Vpx that is ubiquitin-modiﬁed. The bands detected
with anti-Flag mAb from puriﬁed Vpx reactions indicate that Wt
Vpx is ubiquitinated (Fig. 4B). The 23 kDa band represents ubiquitina-
tion of Wt, K68A, and K77A Vpx mutants, but it is not present with
K84A Vpx or TA Vpx mutant. This is also found when the membrane
is blotted with mAb to Vpx (Fig. 4C). These ﬁndings suggest that posi-
tion K84 is the primary attachment site for ubiquitin. Several higher
molecularweight bands that are observedwith all Vpxmutants are pre-
sumed to be ubiquitinated cellular proteins that interact with Vpx and
proteins that non-speciﬁcally bind to Ni-NTA beads (compare lane
with FlagUbK48R to lane with Vpx Wt/FlagUbK48R) (Fig. 4B).
The same membrane blotted with the anti-Vpx mAb provides a
better comparison of endogenous and exogenous ubiquitination
(Fig. 4C). The band pattern observed with anti-Vpx mAb is similar
Fig. 2. Vpx exhibits a perinuclear localization pattern in HeLa cells. The 6xHis-tagged Vpx Wt and 6xHis-tagged Vpx TA constructs were transfected into HeLa cells cultured on cov-
erslips. The cells were ﬁxed, permeabilized, and stained with anti-Vpx and anti-Nup98. Secondary antibodies included Alexa Fluor 488-conjugated goat anti-mouse IgG and Alexa
Fluor 562-conjugated goat anti-rabbit IgG. Nuclei were visualized with TO-PRO3 stain. Confocal microscopy was used to obtain images at 24 h post-transfection.
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The 23 kDa band is present in lanes with Vpx Wt, K68A, and K77A,
representing Vpx that is ubiquitin-modiﬁed, however this 23 kDa
band is absent with the TA and K84A Vpx. Endogenous ubiquitin
modiﬁcation of Vpx can be observed in the same lanes, represented
by bands with a slight faster electropheretic mobility than that of
FlagUbK48R-Vpx. More than 4 bands representing the endogenous ubi-
quitin modiﬁcation are displayed in Vpx Wt, and in Wt/FlagUbK48R
even though this HIV-2 Vpx has only three lysines. This is due to the
fact that endogenous ubiquitin is able to form poly-ubiquitin chains
while UbK48R does not. Endogenous polyubiquitination is also evident
in VpxK68A andK77A lanes. Vpx K84A lacks ubiquitinmodiﬁcation and
is similar to Vpx TA.Ubiquitination has also been reported to occur on non-lysine res-
idues: cysteines, serines, and threonines (Cadwell and Coscoy, 2005;
Herr et al., 2009; Tait et al., 2007). Bonds between ubiquitin and
non-lysine residues are susceptible to alkaline environment due to
the ester bond formation (Wang et al., 2007). The amide bond be-
tween ubiquitin and the lysine residue is more resistant to alkaline
treatment. Although our Vpx TA mutant had no evident ubiquitina-
tion, we wanted to conﬁrm that Vpx Wt was ubiquitin-modiﬁed on
lysine residues. Cells that were transfected with 6xHis-tagged Vpx
Wt and Vpx TA were lysed in denaturing conditions and boiled to dis-
sociate Vpx-interacting proteins. After Vpx puriﬁcation, the lysates
were halved. One half was treated with PBS and the other half was
treated with 0.1 M NaOH. Ubiquitination of Vpx was not disturbed
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Fig. 3. Viral incorporation of HIV-2 VpxWt and Vpx lysine mutants. Immunoblot analysis
of Vpx mutant proteins in 293T cellular lysates and virions. HEK 293T cells were co-
transfected with proviral clone pES or pESdelVpx (which lacks Vpx expression) and
6xHis-tagged VpxWt or mutant constructs. On day three post-transfection, supernatants
were clariﬁed through a 0.22 μm ﬁlter, and virus concentrated on a 20% sucrose cushion.
Cellular and viral lysates were resolved by SDS-PAGE. Both, virus and cell lysates were an-
alyzed byWestern blot with an anti-Vpx mAb and HIV-1 antiserum against Gag. Band in-
tensity was determined by imaging (BioRad Image Lab 3.0). Relative intensity was
normalized to that of capsid (CA) levels, relative to those of pESdelX+Wt. Relative densi-
ty is reported as ratios of supernatant to cellular lysates.
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line treatment of Wt Vpx, in comparison to PBS treatment, indicating
that Wt Vpx is modiﬁed on lysine residues (Fig. 5A). Endogenous ubi-
quitin modiﬁcationwas also observed (Fig. 5B). Conservation of endog-
enous polyubiquitination of Vpx with the alkaline treatment (Wt Vpx
lane) indicates that polyubiquitination occurs on lysine residues
(Fig. 5B). The extra bands in Fig. 5A are the result of the non-speciﬁc
binding of Flag-tagged ubiquitin-modiﬁed proteins to Ni-NTA agarose
beads.
Macrophage infection with HIV-2 Vpx lysine mutants
It is well established that in the absence of Vpx, HIV-2 fails to pro-
ductively infect macrophages (Fletcher et al., 1996; Ueno et al., 2003;
Wolfrum et al., 2007; Yu et al., 1991). A previous study suggested that
ubiquitination is important for Vpx to promote productive infection
of macrophages (Sharova et al., 2008). Thus, we evaluated the infec-
tivity of HIV-2 viruses that carry the Vpx lysine mutants in MDMs.
At 24 h and 48 h after infection, DNA was extracted and used in
real-time PCR assays for detection of early and late reverse transcrip-
tion (RT) products. Trans complementation of pESdelX with Vpx Wt
resulted in macrophage infection levels comparable to that of the
fully infectious ES virus (Fig. 6). However, for TA, K68A, and K77A
Vpx mutants, the early RT products were decreased 3.9, 1.8, and
3.4-fold compared to Wt Vpx. In contrast, for Vpx K84A, the amounts
of early RT product were comparable to those for ES virus and pES-
delX trans complemented with Vpx Wt (Fig. 6). The quantities of
late RT products at 24 h and 48 h time point Vpx TA, K68A, andK77A were decreased 19, 12, 24-fold compared to that for the ES
virus and 12, 8, 16-fold compared to that with pESdelX trans comple-
mented with Vpx Wt, respectively. The K84A mutation did not affect
the levels of early or late RT products 24 h or 48 h after infection, in
comparison to ES virus. The speciﬁcity of the reactions was shown
by the ability of zidovudine (AZT) to block synthesis of late RT products.
The limited effect of AZT on early RT products is consistent with previ-
ous reports (Doitsh et al., 2010).
Lysine mutations and Vpx interaction with DCAF1
Lack of interaction between DCAF1 and Vpx is detrimental to rep-
lication of HIV-2 and SIV in MDMs due to impairment of reverse tran-
scription (Bergamaschi et al., 2009; Le Rouzic et al., 2007; Srivastava
et al., 2008). Based on Vpr mutations, DCAF1 interaction with Vpx
was delineated to position Q76 in Vpx (Le Rouzic et al., 2007). How-
ever, Bergamaschi et al., 2009 reported that mutation at position
K77 in Vpx also interrupts Vpx-DCAF1 binding. Therefore, we exam-
ined whether Vpx lysine mutations affect the interaction between
DCAF1 and Vpx, in order to determine if Vpx ubiquitination is essential
for binding to E3ubiquitin ligase complex. Vpx lysine substitution at po-
sitions K68, K77, and TAdiminished the interaction betweenDCAF1 and
Vpx (Fig. 7). In contrast, Vpx K84A interacted with DCAF1 comparably
to Wt Vpx.
Discussion
Vpx lysine residues are located in regions previously shown to be
important in viral replication. Residue K68 is situated in a nuclear lo-
calization signal thought to be important for the nuclear import of
PICs (Belshan and Ratner, 2003; Belshan et al., 2006). Residue K77 is
adjacent to Q76, which is critical for DCAF1 interaction and, as a re-
sult, binding to an E3 ligase (Le Rouzic et al., 2007). Both residues,
K68 and K77, are highly conserved among HIV-2 and SIV strains,
while position 84 is primarily either a K or an R, depending on the
viral isolate (Mahnke et al., 2006). Conservation of the lysines and re-
gions where they are located indicates their importance in Vpx func-
tion and viral replication.
With our Vpx lysine mutants, we found that while Vpx Wt was
ubiquitinated, marked by the presence of ubiquitin bands detected
with Flag mAb, Vpx TA mutant lost all ubiquitination, as did the Vpx
K84A mutant. We observed that our HIV-2 Vpx K84A mutant lacked
ubiquitination even though other lysine residues were present in
Vpx, at positions 68 and 77. These results are consistentwith the results
reported by Sharova and colleagues, in which SIV Vpx K84Rmutant had
the greatest defect in ubiquitination (Sharova et al., 2008).
When the same membrane was blotted with antibody to Vpx, a
clearer picture of Vpx ubiquitination emerged (Fig. 4C). Wild-type
Vpx alone displayed polyubiquitin modiﬁcation made by endogenous
ubiquitin while Vpx Wt, in conjunction with exogenous ubiquitin,
showed a single band at 23 kDa due to monoubiquitination by the
FlagUbK48R mutant. Several bands corresponding to polyubiquitina-
tion by the endogenous enzyme were also evident. A comparable pat-
tern appeared with Vpx K68A and K77A, while Vpx K84A and TA had
no evidence of modiﬁcation by either endogenous or exogenous ubi-
quitin. These results support our conclusion that position K84 in Vpx
is the primary site for ubiquitination, and that Vpx Wt is
polyubiquitinated.
It is unclear if ubiquitination of Vpx is a result of binding to 1)
SAMHD1, 2) DCAF1 and the Cul4 E3 machinery, or 3) a different ubi-
quitin ligase complex. HIV-1 Vpu has been shown not only to serve as
an adaptor for CD4 degradation, but also as a substrate for an E3 ligase
(Belaidouni et al., 2007). An accessory protein Vif from HIV-1 serves
as an adaptor that brings in the APOBEC3F substrate for ubiquitina-
tion by the Cul5 E3 ligase and as a substrate that is ubiquitinated
(Liu et al., 2005).
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Fig. 4. Effect of Vpx lysine substitution on ubiquitination of Vpx. (A) HEK 293T cells were transfected with 6xHis-tagged Vpx construct and pcDNA (mock). Three days post-
transfection, the cells were lysed, and the proteins resolved by SDS-PAGE and analyzed by Western blot using an anti-Vpx mAb. (B) Assessment of ubiquitination of 6xHis-
tagged Vpx lysine mutants. 293T cells were transfected with 6xHis-tagged Vpx and 6xHis-tagged Vpx lysine mutant constructs in the presence or absence of plasmid that encodes
the Flag-tagged ubiquitin K48R. Three days post-transfection, the cells were lysed and puriﬁed using a Ni-NTA pulldown of 6XHis-tagged Vpx. Lysates were resolved by SDS-PAGE,
and analyzed by blotting for ubiquitinated Vpx with anti-Flag mAb. Lower panel represents a second independent assessment for ubiquitinated Vpx. C) Endogenous ubiquitination
and Vpx expression (Post-pulldown) was detected by re-blotting the Ni-NTA pulldown blot with anti-Vpx mAb. An aliquot of lysates was saved before exposure to Ni-NTA beads
and was blotted with the anti-Vpx mAb (Pre-pulldown). Post-pulldown, Pre-pulldown, and endogenous ubiquitin blot had different exposure times.
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nantly nuclear. However, Vpx exhibits perinuclear and cytoplasmic
localization in a small percentage of cells (Goujon et al., 2007;
Kappes et al., 1993; Mahalingam et al., 2001; Mahnke et al., 2006;
Mueller et al., 2004; Pancio et al., 2000). Wild-type Vpx localized
mainly to the cytoplasm and nucleus (Fig. 2). Vpx TA had more of
an aggregated perinuclear and cytoplasmic distribution. The aggre-
gated phenotype observed with Vpx TA mutant may be attributed
to the triple lysine substitution, which could cause protein destabili-
zation. However, this Vpx mutant was still functional in virus particle
packaging.
After macrophage infection, early and late reverse transcription
products for virions with trans-complemented Wt Vpx were at com-
parable levels to that of Vpx incorporation generated by the fully
functional ES HIV-2. However, virions with Vpx TA, K68A, and K77A
mutants had severely impaired early and late reverse transcription
products compared to the products obtained with ES or with Vpx
Wt virions, indicating that mutations at positions K68 and K77 are
detrimental to reverse transcription. Interestingly, Vpx mutation
K84A had no effect on early or late reverse transcription product
levels and the levels were similar to those observed with Vpx Wt
and ES, indicating that Vpx ubiquitination is dispensable forreplication in MDMs. Sharova et al., 2008, reported that SIV VpxNM2
(K68, 77R mutation) was ubiquitinated but manifested a defect in in-
fectivity. This would indicate that either ubiquitination of K84/K85 or
presence of the amino acid K68 or K77 is essential for replication in
MDMs. The lack of MDM infection with Vpx that has a substitution
at position K77 can be explained by the lack of interaction with
DCAF1 (Bergamaschi et al., 2009). Also, our results demonstrate that
Vpx K68A mutant has severely decreased binding with DCAF1,
whereas, the Vpx K84A mutant interacts with DCAF1. These results
mirror the results obtained with the macrophage infections. Overall,
we demonstrate a novel Vpx residue, K68, that is critical for Vpx–
DCAF1 interaction. Thus far, mutations of residues K68, Q76, K77,
and F80 (SIV Vpx) affect Vpx binding to DCAF1 and consequently
block viral infection. In addition, we show that absence of ubiquitina-
tion on residue K84 of Vpx is dispensable for MDM infection.
Materials and methods
Tissue culture, plasmids, and virus
HeLa, 293T, and TZM-bl cells were maintained in DMEM with 10%
FBS, 1 mM Na-pyruvate and 100 μg/ml penicillin-streptomycin.
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Fig. 5. Alkaline treatment of Vpx. (A) HEK 293T cells were transfected with 6xHis-tagged Vpx construct and pcDNA (mock). Three days post-transfection, the cells were lysed in
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Fig. 6. Effect of Vpx lysine substitutions on viral infectivity. Viral DNA synthesis in human MDMs. The VSV-g pseudotyped cell-free virus was prepared in 293T cells that were co-
transfected with proviral construct pES, and pESdelX (lacks expression of Vpx), and 6xHis-tagged Vpx mutant constructs and pVSV-g. The MDMs were mock infected, infected with
viruses expressed from pES, or pESdelX (which lacks Vpx expression), or viruses expressed from pESdelX trans-complemented with 6xHis-tagged Vpx lysine mutants. Equal
amounts of virus, which was titered on TMZ-bl reporter cells, were used in the infection assays, and all viral samples were treated with DNase I before infection of MDMs. AZT
(10 μM) was added as a control 24 h and 6 h prior to infection to speciﬁed wells. Cellular DNA was extracted at 24 h and 48 h post-infection and subjected to real-time PCR analysis
of early and late reverse transcription products. The data are an average of two independent experiments with error bars representing the standard deviation of the two samples.
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Fig. 7. Vpx lysine substitutions affect the interaction of Vpx with DCAF. HEK 293T cells
were transfected with mock, 6xHis-tagged VpxWt, 6xHis-tagged Vpx TA, 6xHis-tagged
Vpx K68A, 6xHis-tagged Vpx K77A, and 6xHis-tagged Vpx K84A. Forty eight hours
post-transfection, the cells were lysed, and Vpx was immunoprecipitated using anti-
Vpx mAb and Protein A agarose beads. Lysates were resolved with SDS-PAGE and
immunoblotted for DCAF1 and Vpx.
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Modiﬁed Dulbeccos Medium (IMDM), 10% human AB serum, 100 μg/ml
penicillin-streptomycin, 4 mM L-glutamine, and 500 U/ml of recombi-
nant human GM-CSF. MDMs were isolated from peripheral blood of
healthy donors via elutriation.
HIV-2 GH-1 Vpx was expressed as a 6xHis fusion protein (N-ter-
minus) from a pRBG4 vector (Lee et al., 1991). The GH-1 Vpx was
PCR ampliﬁed to include 6xHis tag ﬂanked by EcoRI and ClaI restric-
tion enzyme sites and cloned into pRBG4 that was digested with
EcoRI and ClaI. All lysine to alanine substitutions were generated
with the QuickChange method (Stratagene, La Jolla, CA). The resulting
Vpx lysine plasmids were pRBG4-6xHis-VpxWt, pRBG4-6xHis-VpxTA
(lysine-less), pRBG4-6xHis-VpxK68A, pRBG4-6xHis-VpxK77A, and
pRBG4-6xHis-VpxK84A. The ubiquitin encoding plasmid, CMV2-
Flag-UbK48R, was engineered by PCR ampliﬁcation of K48R ubiquitin
to include ﬂanking NotI and EcoRI restriction sites and ligated into the
N-terminal Flag expression vector pFlag-CMV-2 (Sigma, St. Louis,
MO). All plasmid constructs were veriﬁed by restriction digestion
and sequencing. The HIV-2 functional proviral clones pES and
MX1+62 (referred to as pESdelX in this manuscript) have been de-
scribed previously (Hu et al., 1989). The HIV-2 pESdelX proviral
clone has the 1st and 2nd AUG codons of Vpx eliminated.
Viruses were generated by transfecting 293T cells with pES, pES-
delX, and pESdelX in conjunction with pRBG4-6xHis-VpxWt, pRBG4-
6xHis-VpxTA, pRBG4-6xHis-VpxK68A, pRBG4-6xHis-VpxK77A, and
pRBG4-6xHis-VpxK84A. All viruses were pseudotyped with vesicular
stomatitis virus glycoprotein (VSV-g) and clariﬁed through a 0.22 mi-
cron ﬁlter.
Transfection, immunoprecipitation, and Western blot analysis
The pRBG4-6xHis-VpxWt, pRBG4-6xHis-VpxTA, pRBG4-6xHis-
VpxK68A, pRBG4-6xHis-VpxK77A, and pRBG4-6xHis-VpxK84A vec-
tors were used for transfection of 293T cells. All transfections were
performed using TransIT-LT1 (Mirus Bio) according to the manufac-
turer's instructions. For Vpx lysine mutant expression, 293T cells
were lysed 48 h post-transfection with SDS-PAGE sample buffer,
boiled, and resolved by SDS-PAGE. For viral incorporation experi-
ments, viral supernatants were clariﬁed through a 0.22 micron ﬁlter,
layered on 20% sucrose, and subjected to ultracentrifugation
(45,000 rpm, 1 h, Beckman SW 55 Ti rotor). The viral pellets were
resuspended in SDS-PAGE sample buffer, boiled, and resolved using
SDS-PAGE. For ubiquitination pulldown experiments, 293T cells
were transfected with pRBG4-6xHis-VpxWt, pRBG4-6xHis-VpxTA,
pRBG4-6xHis-VpxK68A, pRBG4-6xHis-VpxK77A, and pRBG4-6xHis-
VpxK84A vectors in the presence or absence of CMV2-Flag-UbK48R
(Ward et al., 1995). After 48 h incubation, Vpx proteins were puriﬁedusing Ni-NTA Magnetic Agarose Beads (Qiagen). Brieﬂy, cells were
lysed under native conditions using TritonX-100 detergent-
containing buffer (10 mM Tris–HCl pH7.5, 150 mM NaCl, 1% Triton
X-100, complete protease inhibitor (Roche), and 5 μM MG132). Pre-
pulldown lysates (10%) were saved for analysis. Lysates were clariﬁed
by centrifugation, buffer was adjusted to 300 mM NaCl, 20 mM Imid-
azole, 5 μM MG132, and beads were added for overnight pulldown.
On the next day, beads were washed with lysis buffer containing
20 mM Imidazole and proteins were eluted in SDS-PAGE sample buffer.
With alkaline treatment of Vpx, transfected cells were lysed in native
conditions, clariﬁed, diluted with RIPA buffer and boiled for 3 min. Ni-
NTA Magnetic Agarose Beads (Qiagen) were used to pulldown Vpx,
which, after several washes, was divided into equal samples. One sam-
ple was treated with PBS (control) and the other sample was treated
with 0.1 M NaOH (Wang et al., 2007). Both samples were incubated
for 2 h at 37 °C, boiled in SDS-PAGE sample buffer, and analyzed by
Western blot. For Vpx-DCAF1 co-immunoprecipitation, 293T cells
were transfected with Vpx lysine mutant constructs and 48 h post-
transfection the cells were lysed using Triton X-100 detergent-
containing buffer (10 mM Tris–HCl pH7.5, 150 mM NaCl, 1% Triton
X-100, and complete protease inhibitor (Roche)). After clariﬁcation,
Vpx-containing lysates were incubated with anti-Vpx mAb overnight.
Protein A agarose beads (Santa Cruz Biotechnology) were used to iso-
late Vpx. Beadswerewashedwith lysis buffer, eluted in SDS-PAGE sam-
ple buffer, boiled, and resolved using SDS-PAGE.
ForWestern blot, Vpx was detected using anti-VpxmAb. Ubiquitin
K48R was detected using anti-Flag mAb (Sigma). DCAF1 was detected
using anti-VprBP pAb (ProteinTech Group). Capsid was detected
using anti-Gag HIV-1 serum that cross reacts with p27.
MDM infection and real-time PCR
Seventy two hours post-transfection, supernatants were clariﬁed
through a 0.22 micron ﬁlter and viral titers were assessed on TZM-
bl reporter cells (Derdeyn et al., 2000; Platt et al., 1998; Wei et al.,
2002). TZM-bl cells were seeded 24 h pre-infection in a 96 well
plate. Supernatants were diluted 1:5 in DMEM supplemented with
2% FBS, and subsequently with 4 sequential 1:5 dilutions. The cells
were incubated with the viral dilutions for 2 h in a 37 °C incubator
supplemented with 5% CO2. After 2 h, DMEM with 10% FBS was
added to each well, and the cells were incubated for additional 48 h.
To determine luciferase activity, cells were lysed and 10 μL of each
sample was transferred to a luciferase tube. Reporter Lysis Buffer
(Promega, Madison, WI) was injected and light intensity was mea-
sured using an OptocompI luminometer. Uninfected cells represented
the background luciferase activity, which was subtracted from all
other samples.
MDMs were allowed to differentiate for a week before equal
amounts of virus were added for infection. All viruses were treated
with Turbo DNase (20 U/ml) (Ambion) for 45 min at 37 °C. Cells
were cultured for 24 h and 48 h after infection, at which point DNA
was collected for detection of reverse transcription products. Macro-
phage DNA was isolated using DNeasy tissue kit (Qiagen). Real-time
PCR (iCycler; BioRad) was used to detect early and late reverse tran-
scription products using iQ Supermix reagent (BioRad) and primers
for early U5 and late gag gene reverse transcription products. Stan-
dards were made using proviral plasmid pES.
Localization in HeLa cells
The pRBG4-6xHis-VpxWt and pRBG4-6xHis-VpxTA plasmids were
used for transfection of HeLa cells that were seeded 24 h pre-
transfection on coverslips. pRBG4 was used as mock control. Twenty
four hours post-transfection, cells were washed with 1× PBS, ﬁxed
with 2% formaldehyde, washed, permeabilized with 0.2% Triton
X-100 in PBS for 6 min, and stained with anti-Vpx mAb and anti-
74 A. McCulley, L. Ratner / Virology 427 (2012) 67–75Nup98 pAb in 1XPBS/5%BSA for 1 h. After a wash step, the cells were
stained with Alexa Fluor-488 (mouse) and Alexa Fluor-562 (rabbit)
(Molecular Probes) for 15 min in the dark. Nuclei were counter-
stained with TO-PRO3 (Invitrogen). Cells were visualized using
LSM-510-META Laser Scanning Confocal Microscope.
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